课题基金 / 基金详情

Epidemiology, Diagnosis, and Treatment of Cardiac Toxicity in Patients Receiving Cancer Therapy - An "Onco-cardiology" Initiative

Epidemiology, Diagnosis, and Treatment of Cardiac Toxicity in Patients Receiving Cancer Therapy - An "Onco-cardiology" Initiative
接受癌症治疗的患者心脏毒性的流行病学、诊断和治疗——“肿瘤心脏病学”倡议
批准号:
340769
负责人:
Thavendiranathan Paaladinesh
金额:
$21.86万
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-12-01 至 2020-12-01

项目摘要

项目成果

Thavendiranathan Paaladinesh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Advances in cancer treatment over the past 25 years have allowed patients to survive well beyond their cancer diagnosis. Unfortunately, the drugs used to treat these cancers can cause heart damage resulting in heart failure (HF). The need to better unders
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients with Normalized Cancer Therapy Related Cardiac Dysfunction - The STOP-MED CTRCD Trial
  • 批准号:
    489331
  • 项目类别:
    Operating Grants
  • 资助金额:
    $150.47万
  • 财政年份:
    2023
  • 负责人:
    Thavendiranathan Paaladinesh
  • 依托单位:
Predicting Risk and Identifying Mechanisms of Cardiotoxicity in Breast Cancer Patients - Application of Novel Biomarkers
  • 批准号:
    435909
  • 项目类别:
    Operating Grants
  • 资助金额:
    $60.19万
  • 财政年份:
    2020
  • 负责人:
    Thavendiranathan Paaladinesh
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    415403
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    2019
  • 负责人:
    Thavendiranathan Paaladinesh
  • 依托单位:
Evaluation of Myocardial changes during BReast Adenocarcinoma therapy to detect Cardiotoxicity Earlier with MRI- The EMBRACE-MRI Study
  • 批准号:
    322085
  • 项目类别:
    Operating Grants
  • 资助金额:
    $46.71万
  • 财政年份:
    2015
  • 负责人:
    Thavendiranathan Paaladinesh
  • 依托单位:
海外基金